Last update March 5, 2022
Most cardiac diseases on the mother when compensated by appropriate treatment are not a contraindication of breastfeeding. (Mayo Clinic 2022, Kearney 2018, Protocolo Barcelona 2018, Greutmann 2015)
Patients with functional class IV of the New York Heart Association (NYHA) functional classification probably should not or cannot breastfeed. A consensual breastfeeding plan must be established for patients with WHO risk levels III and IV who require a stay in intensive care after delivery.
Dosage has to be adjusted and cardiovascular drugs properly chosen. (Kearney 2018)
Use low dosing of diuretic drugs because the mammary gland acts as a excretory organ of about 1 liter of fluid every day.
It is also necessary to take into account the higher caloric expenditure involved in breastfeeding (1 liter of breast milk is equivalent to about 700 calories).
Given the strong evidence that exists on the benefits of breastfeeding for the development of babies and the health of mothers, it is advisable to evaluate the risk-benefit of any maternal treatment, individually advising each mother that wishes to continue with breastfeeding. (Koren 2013)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM